Cargando…

Chemosaturation with percutaneous hepatic perfusion is effective in patients with ocular melanoma and cholangiocarcinoma

BACKGROUND: Chemosaturation with percutaneous hepatic perfusion (CS-PHP; Hepatic CHEMOSAT® Delivery System; Delcath Systems Inc, USA) is a novel interventional procedure, which delivers high doses of melphalan directly to the liver in patients with liver tumors while limiting systemic toxicity throu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schönfeld, Leon, Hinrichs, Jan B., Marquardt, Steffen, Voigtländer, Torsten, Dewald, Cornelia, Koppert, Wolfgang, Manns, Michael P., Wacker, Frank, Vogel, Arndt, Kirstein, Martha M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Original Article – Clinical Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519914/ https://www.ncbi.nlm.nih.gov/pubmed/32564137 http://dx.doi.org/10.1007/s00432-020-03289-5

Ejemplares similares

New perspectives in unresectable cholangiocarcinoma? Evaluation of chemosaturation with percutaneous hepatic perfusion as a palliative treatment option
por: Dewald, Cornelia L. A., et al.
Publicado: (2022)

Chemosaturation Percutaneous Hepatic Perfusion: A Systematic Review
por: Vogel, Arndt, et al.
Publicado: (2016)

Percutaneous isolated hepatic perfusion (chemosaturation) with melphalan following right hemihepatectomy in patients with cholangiocarcinoma and metastatic uveal melanoma: peri- and post-interventional adverse events and therapy response compared to a matched group without prior liver surgery
por: Dewald, C. L. A., et al.
Publicado: (2020)

Chemosaturation with percutaneous hepatic perfusion of melphalan for metastatic uveal melanoma
por: Modi, Sachin, et al.
Publicado: (2022)

Initiation of Chemosaturation With Percutaneous Hepatic Perfusion Program in Interventional Radiology Department
por: Öcal, Osman, et al.
Publicado: (2021)

Percutaneous Hepatic Perfusion (PHP) with Melphalan in Liver-Dominant Metastatic Uveal Melanoma: The German Experience
por: Dewald, Cornelia L. A., et al.
Publicado: (2021)

Heparin reversal with protamine sulfate after Percutaneous Hepatic Perfusion (PHP): is less more?
por: Facchetti, Nadia, et al.
Publicado: (2023)

Molecular Subtypes and Precision Oncology in Intrahepatic Cholangiocarcinoma
por: Czauderna, Carolin, et al.
Publicado: (2021)

Chemosaturation with percutaneous hepatic perfusion of melphalan for liver-dominant metastatic uveal melanoma: a single center experience
por: Artzner, Christoph, et al.
Publicado: (2019)

Fulminant Hepatic Failure after Chemosaturation with Percutaneous Hepatic Perfusion and Nivolumab in a Patient with Metastatic Uveal Melanoma
por: Teal, Lindsey, et al.
Publicado: (2021)

Bile and urine peptide marker profiles: access keys to molecular pathways and biological processes in cholangiocarcinoma
por: Voigtländer, Torsten, et al.
Publicado: (2020)

Selective Internal Radiotherapy (SIRT) and Chemosaturation Percutaneous Hepatic Perfusion (CS-PHP) for Metastasized Uveal Melanoma: A Retrospective Comparative Study
por: Kolb, Manuel, et al.
Publicado: (2023)

Endoscopic decompression of acute intestinal distension is associated with reduced mortality in critically ill patients
por: Book, Thorsten, et al.
Publicado: (2020)

Secondary sclerosing cholangitis in critically ill patients has a poor outcome but lower tumour incidence than primary sclerosing cholangitis
por: Kirstein, Martha M, et al.
Publicado: (2020)

Evaluation of perfusion changes using a 2D Parametric Parenchymal Blood Flow technique with automated vessel suppression following partial spleen embolization in patients with hypersplenism and portal hypertension
por: Meine, Timo C., et al.
Publicado: (2021)

Prognostic Factors for Postoperative Bleeding Complications and Prolonged Intensive Care after Percutaneous Hepatic Chemosaturation Procedures with Melphalan
por: Struck, Manuel Florian, et al.
Publicado: (2023)

Angiopoietin-2 and Biliary Diseases: Elevated Serum, but Not Bile Levels Are Associated with Cholangiocarcinoma
por: Voigtländer, Torsten, et al.
Publicado: (2014)

MicroRNAs in Serum and Bile of Patients with Primary Sclerosing Cholangitis and/or Cholangiocarcinoma
por: Voigtländer, Torsten, et al.
Publicado: (2015)

Comparison of the Uptake of Hepatocellular Carcinoma on Pre-Therapeutic MDCT, CACT, and SPECT/CT, and the Correlation with Post-Therapeutic PET/CT in Patients Undergoing Selective Internal Radiation Therapy
por: Meine, Timo C., et al.
Publicado: (2021)

Radial Artery Access for Hepatic Chemosaturation: The First Description of Technical Feasibility
por: Frost, Joshua P, et al.
Publicado: (2021)

Anästhesiologisches und postinterventionelles Management bei perkutaner hepatischer Melphalanperfusion (Chemosaturation)
por: Kliem, Peter, et al.
Publicado: (2022)

2D-Perfusion Angiography Using Carbon Dioxide (CO2): A Feasible Tool to Monitor Immediate Treatment Response to Endovascular Therapy of Peripheral Arterial Disease?
por: Dewald, Cornelia L. A., et al.
Publicado: (2020)

Dilatation Therapy and Demographic Characteristics Significantly Influence the Amount of Propofol for Therapeutic Endoscopic Retrograde Cholangiography
por: Schmidt, Christoph A., et al.
Publicado: (2019)

Portal Vein Recanalization–Transjugular Intrahepatic Portosystemic Shunt (PVR-TIPS) with superior mesenteric vein access and balloon-assisted shunt placement
por: Dewald, Cornelia L. A., et al.
Publicado: (2023)

Analysis of patient’s X-ray exposure in hepatic chemosaturation procedures: a single center experience
por: Ebel, Sebastian, et al.
Publicado: (2022)

First-line molecular therapies in the treatment of metastatic colorectal cancer – a literature-based review of phases II and III trials
por: Vogel, Arndt, et al.
Publicado: (2018)

Transjugular intrahepatic portosystemic shunt placement: portal vein puncture guided by 3D/2D image registration of contrast-enhanced multi-detector computed tomography and fluoroscopy
por: Meine, Timo C., et al.
Publicado: (2020)

Coil embolization of reversed-curve hepatointestinal collaterals in radioembolization: potential solutions for a challenging task
por: Hinrichs, Jan B., et al.
Publicado: (2017)

Non-occlusive mesenteric ischemia (NOMI): evaluation of 2D-perfusion angiography (2D-PA) for early treatment response assessment
por: Becker, Lena S., et al.
Publicado: (2020)

Thrombotischer Verschluss der extrakorporalen Zirkulation während hepatischer Chemosaturation trotz zielgerechter Antikoagulation: Ein Fallbericht
por: Kuhner, M., et al.
Publicado: (2022)

Evaluation of a Motion Correction Algorithm for C-Arm Computed Tomography Acquired During Transarterial Chemoembolization
por: Becker, Lena S., et al.
Publicado: (2020)

Depiction of mosaic perfusion in chronic thromboembolic pulmonary hypertension (CTEPH) on C-arm computed tomography compared to computed tomography pulmonary angiogram (CTPA)
por: Maschke, Sabine K., et al.
Publicado: (2021)

Predictive Parameters in Patients Undergoing Percutaneous Hepatic Perfusion with Melphalan for Unresectable Liver Metastases from Uveal Melanoma: A Retrospective Pooled Analysis
por: Tong, T. M. L., et al.
Publicado: (2022)

A New Option for the Treatment of Intrahepatic Cholangiocarcinoma: Percutaneous Hepatic Perfusion with CHEMOSAT Delivery System
por: Ferrucci, Pier Francesco, et al.
Publicado: (2021)

Endoscopic vacuum-assisted closure therapy for leakage of the lower gastrointestinal tract: multicenter experiences
por: Book, Thorsten, et al.
Publicado: (2023)

Is There Any Evidence for a Role of Local Treatment in Cholangiocarcinoma?
por: Vogel, Arndt, et al.
Publicado: (2014)

Percutaneous Transsplenic Balloon-Assisted Transjugular Intrahepatic Portosystemic Shunt Placement in Patients with Portal Vein Obliteration for Portal Vein Recanalization: Feasibility, Safety and Effectiveness
por: Meine, T. C., et al.
Publicado: (2022)

FGFR inhibitors in cholangiocarcinoma: what’s now and what’s next?
por: Saborowski, Anna, et al.
Publicado: (2020)

Ocular perfusion pressure and ocular blood flow in glaucoma
por: Cherecheanu, A Popa, et al.
Publicado: (2013)

Increased seroprevalence of HAV and parvovirus B19 in children and of HEV in adults at diagnosis of autoimmune hepatitis
por: Taubert, Richard, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4b54946fslnnqq267gc4lho8ed